Goldman Sachs’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21K Buy
+10,369
New +$21K ﹤0.01% 5041
2024
Q4
Sell
-12,657
Closed -$47.8K 5005
2024
Q3
$47.8K Sell
12,657
-672
-5% -$2.54K ﹤0.01% 4666
2024
Q2
$53.2K Sell
13,329
-10,280
-44% -$41K ﹤0.01% 4557
2024
Q1
$69.9K Buy
23,609
+6,319
+37% +$18.7K ﹤0.01% 4506
2023
Q4
$86.5K Buy
+17,290
New +$86.5K ﹤0.01% 4484
2023
Q1
Sell
-18,867
Closed -$38.5K 5098
2022
Q4
$38.5K Sell
18,867
-7,710
-29% -$15.7K ﹤0.01% 4822
2022
Q3
$84K Sell
26,577
-2,305
-8% -$7.29K ﹤0.01% 4960
2022
Q2
$104K Buy
28,882
+75
+0.3% +$270 ﹤0.01% 5104
2022
Q1
$115K Buy
28,807
+2,184
+8% +$8.72K ﹤0.01% 5269
2021
Q4
$132K Sell
26,623
-7,068
-21% -$35K ﹤0.01% 5135
2021
Q3
$226K Buy
33,691
+292
+0.9% +$1.96K ﹤0.01% 4816
2021
Q2
$265K Sell
33,399
-22,149
-40% -$176K ﹤0.01% 4772
2021
Q1
$423K Buy
55,548
+3,959
+8% +$30.1K ﹤0.01% 4465
2020
Q4
$267K Buy
51,589
+12,268
+31% +$63.5K ﹤0.01% 4132
2020
Q3
$192K Sell
39,321
-19,271
-33% -$94.1K ﹤0.01% 4071
2020
Q2
$394K Buy
58,592
+32,187
+122% +$216K ﹤0.01% 3700
2020
Q1
$182K Sell
26,405
-14,675
-36% -$101K ﹤0.01% 3972
2019
Q4
$350K Buy
41,080
+13,474
+49% +$115K ﹤0.01% 3811
2019
Q3
$137K Buy
27,606
+4,291
+18% +$21.3K ﹤0.01% 4002
2019
Q2
$129K Sell
23,315
-9,214
-28% -$51K ﹤0.01% 3957
2019
Q1
$164K Buy
32,529
+5,338
+20% +$26.9K ﹤0.01% 3934
2018
Q4
$257K Buy
+27,191
New +$257K ﹤0.01% 3658
2017
Q3
Sell
-14,475
Closed -$127K 4258
2017
Q2
$127K Buy
+14,475
New +$127K ﹤0.01% 4092
2017
Q1
Sell
-10,495
Closed -$136K 4390
2016
Q4
$136K Sell
10,495
-18,616
-64% -$241K ﹤0.01% 4016
2016
Q3
$479K Buy
+29,111
New +$479K ﹤0.01% 3459